Possible association between ubiquitin-specific peptidase 46 gene and major depressive disorders in the Japanese population

Journal of Affective Disorders

Volumn 133, Issue 1-2, 2011, Pages 150-157

  Fukuo, Yasuhisa ^a   Kishi, Taro ^a,b   Kushima, Itaru ^c   Yoshimura, Reiji ^d   Okochi, Tomo ^a   Kitajima, Tsuyoshi ^a   Matsunaga, Shinji ^a   Kawashima, Kunihiro ^a   Umene Nakano, Wakako ^d   Naitoh, Hiroshi ^a   Inada, Toshiya ^e   Nakamura, Jun ^d   Ozaki, Norio ^c   Iwata, Nakao ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b ZUCKER HILLSIDE HOSPITAL   (United States)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^e SEIWA HOSPITAL   (Japan)

Author keywords

Case control study; Linkage disequilibrium; Major depressive disorder; Pharmacogenic study; Selective serotonin reuptake inhibitors (SSRIs) response; Tagging SNP; Ubiquitin specific peptidase 46 (USP46) gene

Indexed keywords

BENZODIAZEPINE; FLUVOXAMINE; PAROXETINE; PROTEIN; SERTRALINE; UBIQUITIN SPECIFIC PEPTIDASE 46; UNCLASSIFIED DRUG;

ANXIETY DISORDER; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG EFFICACY; GENE FREQUENCY; GENETIC ASSOCIATION; HAMILTON SCALE; HAPLOTYPE; HUMAN; INSOMNIA; JAPANESE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PHARMACOGENETICS; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CIRCADIAN CLOCKS; DEPRESSIVE DISORDER, MAJOR; ENDOPEPTIDASES; FEMALE; FLUVOXAMINE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; PAROXETINE; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; TREATMENT OUTCOME; UBIQUITIN;

EID: 80051667505     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2011.04.020     Document Type: Article

References (40)

1. B. Barbini, F. Benedetti, C. Colombo, E. Guglielmo, E. Campori, and E. Smeraldi Perceived mood and skin body temperature rhythm in depression European Archives of Psychiatry and Clinical Neuroscience 248 1998 157 160 (Pubitemid 28396011)
2. J.C. Barrett, B. Fry, J. Maller, and M.J. Daly Haploview: analysis and visualization of LD and haplotype maps Bioinformatics (Oxford, England) 21 2005 263 265 (Pubitemid 40202029)
3. F.J. Bosker, C.A. Hartman, I.M. Nolte, B.P. Prins, P. Terpstra, D. Posthuma, T. van Veen, G. Willemsen, R.H. Derijk, E.J. de Geus, W.J. Hoogendijk, P.F. Sullivan, B.W. Penninx, D.I. Boomsma, H. Snieder, and W.A. Nolen Poor replication of candidate genes for major depressive disorder using genome-wide association data Molecular Psychiatry 2010
4. C.L. Bowden Strategies to reduce misdiagnosis of bipolar depression Psychiatric Services (Washington, D.C.) 52 2001 51 55 (Pubitemid 32039805)
5. H.J. Cho, H. Lavretsky, R. Olmstead, M.J. Levin, M.N. Oxman, and M.R. Irwin Sleep disturbance and depression recurrence in community-dwelling older adults: a prospective study The American Journal of Psychiatry 165 2008 1543 1550
6. S. Cichon, N. Craddock, M. Daly, S.V. Faraone, P.V. Gejman, J. Kelsoe, T. Lehner, D.F. Levinson, A. Moran, P. Sklar, and P.F. Sullivan Genomewide association studies: history, rationale, and prospects for psychiatric disorders The American Journal of Psychiatry 166 2009 540 556
7. P.G.C.C. Committee A framework for interpreting genome-wide association studies of psychiatric disorders Molecular Psychiatry 14 2009 10 17
8. F. Dudbridge Pedigree disequilibrium tests for multilocus haplotypes Genetic Epidemiology 25 2003 115 121 (Pubitemid 37064867)
9. Y. Fukuo, T. Kishi, T. Okochi, T. Kitajima, T. Tsunoka, T. Okumukura, Y. Kinoshita, K. Kawashima, Y. Yamanouchi, W. Umene-Nakano, H. Naitoh, T. Inada, R. Yoshimura, J. Nakamura, N. Ozaki, and N. Iwata Lack of association between MAGEL2 and schizophrenia and mood disorders in the Japanese population Neuromolecular Medicine 2010
10. Y. Fukuo, T. Kishi, R. Yoshimura, T. Kitajima, T. Okochi, Y. Yamanouchi, Y. Kinoshita, K. Kawashima, H. Naitoh, W. Umene-Nakano, T. Inada, H. Kunugi, T. Kato, T. Yoshikawa, H. Ujike, J. Nakamura, N. Ozaki, and N. Iwata Serotonin 6 receptor gene and mood disorders: case-control study and meta-analysis Neuroscience Research 67 2010 250 255
11. P.L. Haynes, J.R. McQuaid, S. Ancoli-Israel, and J.L. Martin Disrupting life events and the sleep-wake cycle in depression Psychological Medicine 36 2006 1363 1373 (Pubitemid 44355972)
12. T. Kato Molecular genetics of bipolar disorder and depression Psychiatry and Clinical Neurosciences 61 2007 3 19 (Pubitemid 46089400)
13. T. Kishi, T. Kitajima, M. Ikeda, Y. Yamanouchi, Y. Kinoshita, K. Kawashima, T. Okochi, N. Ozaki, and N. Iwata Association analysis of nuclear receptor Rev-erb alpha gene (NR1D1) with mood disorders in the Japanese population Neuroscience Research 62 2008 211 215
14. T. Kishi, T. Kitajima, M. Ikeda, Y. Yamanouchi, Y. Kinoshita, K. Kawashima, T. Okochi, T. Okumura, T. Tsunoka, T. Inada, N. Ozaki, and N. Iwata Association study of clock gene (CLOCK) and schizophrenia and mood disorders in the Japanese population European Archives of Psychiatry and Clinical Neuroscience 259 2009 293 297
15. T. Kishi, T. Kitajima, M. Ikeda, Y. Yamanouchi, Y. Kinoshita, K. Kawashima, T. Okochi, T. Okumura, T. Tsunoka, N. Ozaki, and N. Iwata CLOCK may predict the response to fluvoxamine treatment in Japanese major depressive disorder patients Neuromolecular Medicine 11 2009 53 57
16. T. Kishi, T. Kitajima, M. Ikeda, Y. Yamanouchi, Y. Kinoshita, K. Kawashima, T. Okochi, N. Ozaki, and N. Iwata Orphan nuclear receptor Rev-erb alpha gene (NR1D1) and fluvoxamine response in major depressive disorder in the Japanese population Neuropsychobiology 59 2009 234 238
17. T. Kishi, T. Kitajima, T. Tsunoka, M. Ikeda, Y. Yamanouchi, Y. Kinoshita, K. Kawashima, T. Okochi, T. Okumura, T. Inada, N. Ozaki, and N. Iwata Genetic association analysis of serotonin 2A receptor gene (HTR2A) with bipolar disorder and major depressive disorder in the Japanese population Neuroscience Research 64 2009 231 234
18. T. Kishi, T. Kitajima, T. Tsunoka, T. Okumura, M. Ikeda, T. Okochi, Y. Kinoshita, K. Kawashima, Y. Yamanouchi, N. Ozaki, and N. Iwata Possible association of prokineticin 2 receptor gene (PROKR2) with mood disorders in the Japanese population Neuromolecular Medicine 11 2009 114 122
19. T. Kishi, T. Tsunoka, M. Ikeda, K. Kawashima, T. Okochi, T. Kitajima, Y. Kinoshita, T. Okumura, Y. Yamanouchi, T. Inada, N. Ozaki, and N. Iwata Serotonin 1A receptor gene and major depressive disorder: an association study and meta-analysis Journal of Human Genetics 54 2009 629 633
20. T. Kishi, T. Tsunoka, M. Ikeda, T. Kitajima, K. Kawashima, T. Okochi, T. Okumura, Y. Yamanouchi, Y. Kinoshita, H. Ujike, T. Inada, M. Yamada, N. Uchimura, I. Sora, M. Iyo, N. Ozaki, and N. Iwata Serotonin 1A receptor gene is associated with Japanese methamphetamine-induced psychosis patients Neuropharmacology 58 2010 452 456
21. T. Kishi, R. Yoshimura, T. Kitajima, T. Okochi, T. Okumura, T. Tsunoka, Y. Yamanouchi, Y. Kinoshita, K. Kawashima, Y. Fukuo, H. Naitoh, W. Umene-Nakano, T. Inada, J. Nakamura, N. Ozaki, and N. Iwata SIRT1 gene is associated with major depressive disorder in the Japanese population Journal of Affective Disorders 2010
22. T. Kishi, R. Yoshimura, T. Okochi, Y. Fukuo, T. Kitajima, T. Okumura, T. Tsunoka, K. Kawashima, Y. Yamanouchi, Y. Kinoshita, W. Umene-Nakano, H. Naitoh, J. Nakamura, N. Ozaki, and N. Iwata Association analysis of SIGMAR1 with major depressive disorder and SSRI response Neuropharmacology 58 2010 1168 1173
23. I. Kushima, B. Aleksic, Y. Ito, Y. Nakamura, K. Nakamura, N. Mori, M. Kikuchi, T. Inada, H. Kunugi, S. Nanko, T. Kato, T. Yoshikawa, H. Ujike, M. Suzuki, N. Iwata, and N. Ozaki Association study of ubiquitin-specific peptidase 46 (USP46) with bipolar disorder and schizophrenia in a Japanese population Journal of Human Genetics 55 2010 133 136
24. C.A. McClung Circadian genes, rhythms and the biology of mood disorders Pharmacology & Therapeutics 114 2007 222 232 (Pubitemid 46561535)
25. C.A. McClung Clock genes and bipolar disorder: implications for therapy Pharmacogenomics 8 2007 1097 1100 (Pubitemid 47578218)
26. C.A. McClung Role for the Clock gene in bipolar disorder Cold Spring Harbor Symposia on Quantitative Biology 72 2007 637 644
27. P. Monteleone, and M. Maj The circadian basis of mood disorders: recent developments and treatment implications European Neuropsychopharmacology 18 2008 701 711
28. P. Muglia, F. Tozzi, N.W. Galwey, C. Francks, R. Upmanyu, X.Q. Kong, A. Antoniades, E. Domenici, J. Perry, S. Rothen, C.L. Vandeleur, V. Mooser, G. Waeber, P. Vollenweider, M. Preisig, S. Lucae, B. Muller-Myhsok, F. Holsboer, L.T. Middleton, and A.D. Roses Genome-wide association study of recurrent major depressive disorder in two European case-control cohorts Molecular Psychiatry 15 2010 589 601
29. R. Peveler, and T. Kendrick Selective serotonin reuptake inhibitors: THREAD trial may show way forward BMJ (Clinical research ed.) 330 2005 420 421
30. S. Purcell, S.S. Cherny, and P.C. Sham Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits Bioinformatics (Oxford, England) 19 2003 149 150 (Pubitemid 36150192)
31. D. Riemann, F. Hohagen, M. Bahro, and M. Berger Sleep in depression: the influence of age, gender and diagnostic subtype on baseline sleep and the cholinergic REM induction test with RS 86 European Archives of Psychiatry and Clinical Neuroscience 243 1994 279 290 (Pubitemid 24083882)
32. S. Saito, N. Takahashi, R. Ishihara, M. Ikeda, T. Suzuki, T. Kitajima, Y. Yamanouchi, N. Iwata, M. Yamada, K. Yoshida, T. Inada, and N. Ozaki Association study between vesicle-associated membrane protein 2 gene polymorphisms and fluvoxamine response in Japanese major depressive patients Neuropsychobiology 54 2006 226 230
33. J.A. Samson, S.M. Mirin, M. Griffin, D. Borrelli, and J.J. Schildkraut Urinary MHPG and clinical symptoms in patients with unipolar depression Psychiatry Research 51 1994 157 165 (Pubitemid 24067889)
34. G. Sanacora Cortical inhibition, gamma-aminobutyric acid, and major depression: there is plenty of smoke but is there fire? Biological Psychiatry 67 2010 397 398
35. J. Shi, J.B. Potash, J.A. Knowles, M.M. Weissman, W. Coryell, W.A. Scheftner, W.B. Lawson, J.R. Depaulo Jr., P.V. Gejman, A.R. Sanders, J.K. Johnson, P. Adams, S. Chaudhury, D. Jancic, O. Evgrafov, A. Zvinyatskovskiy, N. Ertman, M. Gladis, K. Neimanas, M. Goodell, N. Hale, N. Ney, R. Verma, D. Mirel, P. Holmans, and D.F. Levinson Genome-wide association study of recurrent early-onset major depressive disorder Molecular Psychiatry 2010
36. Soria, V., Martinez-Amoros, E., Escaramis, G., Valero, J., Perez-Egea, R., Garcia, C., Gutierrez-Zotes, A., Puigdemont, D., Bayes, M., Crespo, J.M., Martorell, L., Vilella, E., Labad, A., Vallejo, J., Perez, V., Menchon, J.M., Estivill, X., Gratacos, M., Urretavizcaya, M., Differential association of circadian genes with mood disorders: CRY1 and NPAS2 are associated with unipolar major depression and CLOCK and VIP with bipolar disorder. Neuropsychopharmacology 35, 1279-1289.
37. J. Sprouse, J. Braselton, and L. Reynolds Fluoxetine modulates the circadian biological clock via phase advances of suprachiasmatic nucleus neuronal firing Biological Psychiatry 60 2006 896 899 (Pubitemid 44527886)
38. S. Tomida, T. Mamiya, H. Sakamaki, M. Miura, T. Aosaki, M. Masuda, M. Niwa, T. Kameyama, J. Kobayashi, Y. Iwaki, S. Imai, A. Ishikawa, K. Abe, T. Yoshimura, T. Nabeshima, and S. Ebihara Usp46 is a quantitative trait gene regulating mouse immobile behavior in the tail suspension and forced swimming tests Nature Genetics 2009
39. T. Uz, R. Ahmed, M. Akhisaroglu, M. Kurtuncu, M. Imbesi, A. Dirim Arslan, and H. Manev Effect of fluoxetine and cocaine on the expression of clock genes in the mouse hippocampus and striatum Neuroscience 134 2005 1309 1316 (Pubitemid 41207379)
40. J.B. Williams A structured interview guide for the Hamilton Depression Rating Scale Archives of General Psychiatry 45 1988 742 747